drugset / Trial / NCT00995722
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Phase 3
Terminated
11 enrolled
Michael Benatar
University of Miami · collabUniversity of Rochester · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and tolerability of prednisone in patients diagnosed with ocular myasthenia. Funding Source - FDA OOPD
Timeline
- Start
- 2011-12
- Primary completion
- 2013-10
- Completion
- 2013-10
Outcome
Outcome not reported
Stopped (Enrollment): “Slow recruitment rate”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisone | Other / unclassified | 10 mg | — |